Düzenli hemodiyaliz tedavisi uygulanan hastalarda L-karnitin tedavisinin insülin direnci ve lipit profili üzerine etkileri
Başlık çevirisi mevcut değil.
- Tez No: 164563
- Danışmanlar: PROF.DR. EMİN YILMAZ
- Tez Türü: Tıpta Uzmanlık
- Konular: Nefroloji, Nephrology
- Anahtar Kelimeler: Belirtilmemiş.
- Yıl: 2005
- Dil: Türkçe
- Üniversite: Dicle Üniversitesi
- Enstitü: Tıp Fakültesi
- Ana Bilim Dalı: İç Hastalıkları Ana Bilim Dalı
- Bilim Dalı: Belirtilmemiş.
- Sayfa Sayısı: Belirtilmemiş.
Özet
Findings: We established insulin resistance (H0MA-IR>1,93) in %24 of patients. A significant relation was'nt determined between HOMA-IR and PTH levels, hematocrit value and rHuEpo treatment (p>0,05). Significant change was'nt determined im HOMA-IR, insulin, glucose, total cholesterol, triglyceride, HDL-C, LDL-C levels after treatment in L-carnitine group (p>0,05). Also there was'nt a significant change in HOMA-IR, glucose, total cholesterol, triglyceride, HDL-C, LDL-C levels in placebo conrol group (p>0,05). Significant increase was determined in insulin levels (p<0,05). Result: We established that IR, has a predictor role on cardiovasculer mortality in ESRD, is a reversible risk factor by adequate hemodialysis therapy. L-carnitine did'nt made evident effect on IR and lipid levels. 65ilişki saptanmadı (p>0,05). L karnitin grubunda tedavi sonrası HOMA-IR, insülin, glukoz, total kolesterol, trigliserid, HDL-K, LDL-K değerlerinde anlamlı değişiklik görülmedi (P>0,05). Plasebo kontrol grubunda da tedavi sonrası HOMA-IR, glukoz, total kolesterol, trigliserid, LDL-K, HDL-K' de anlamlı değişiklik görülmedi (P>0,05). însülin düzeylerinde ise anlamlı artış saptandı (p<0,05). Sonuç: Yeterli HD tedavisiyle SDBH'da kardiyovasküler mortalite üzerinde belirleyici bir rolü olan IR'nın değiştirilebilir bir risk faktörü olduğunu tespit ettik. L karnitin tedavisi ise İR ve lipid profiline belirgin bir etki yapmamıştır. SUMMARY Aim: Cardiovasculer diseases are major mortality causes in patients that underwent to hemodialysis and periton dialysis as it is in normal population. însülin resistance is associated with cardiovasculer diseases that develops on the basis of atherogenesis. The relation between uremia and insulin resistance are known for many years. Uremia also causes lipid metabolism disorders. We studied prevelance of HOMA-IR, relation of HOMA-IR and other parameters, and effect of L-carnitine teratment on IR and lipid levels in hemodialysis patients. Materials and Method: 58 patients (23 men, 35 women) mat were underwent to hemodialysis three times in a week for at least six months were included. Patients that were diabetic, has a family history of diabetes, obese, unstabil and suffered from active infection were excluded. Patients were divided in two groups as L- carnitine therapy group (n:29) and placebo control group (n:29). There was not a difference between grups according to average age, duration of hemodialysis, BMI and dialysis adequacy (Kt/V). Mean age was 39±13,6 in L-carnitine grup and 39±12,8 in placebo group. L-carnitine was given 1 g IV after each dialysis for one months. 5 cc serum physiologic was given after each dialysis in placebo control group. H0MA-IR>1,93 accepted as insulin resistance. Patients were classified according to PTH levels, hematocrit values and rHuEpo treatment. HOMA-IR values were compared. Blood samples were collected at 8:30 am after 12 hours hunger. It was measured in Central Laboratory of Dicle University Medical Faculty. 64
Özet (Çeviri)
ilişki saptanmadı (p>0,05). L karnitin grubunda tedavi sonrası HOMA-IR, insülin, glukoz, total kolesterol, trigliserid, HDL-K, LDL-K değerlerinde anlamlı değişiklik görülmedi (P>0,05). Plasebo kontrol grubunda da tedavi sonrası HOMA-IR, glukoz, total kolesterol, trigliserid, LDL-K, HDL-K' de anlamlı değişiklik görülmedi (P>0,05). însülin düzeylerinde ise anlamlı artış saptandı (p<0,05). Sonuç: Yeterli HD tedavisiyle SDBH'da kardiyovasküler mortalite üzerinde belirleyici bir rolü olan IR'nın değiştirilebilir bir risk faktörü olduğunu tespit ettik. L karnitin tedavisi ise İR ve lipid profiline belirgin bir etki yapmamıştır. SUMMARY Aim: Cardiovasculer diseases are major mortality causes in patients that underwent to hemodialysis and periton dialysis as it is in normal population. însülin resistance is associated with cardiovasculer diseases that develops on the basis of atherogenesis. The relation between uremia and insulin resistance are known for many years. Uremia also causes lipid metabolism disorders. We studied prevelance of HOMA-IR, relation of HOMA-IR and other parameters, and effect of L-carnitine teratment on IR and lipid levels in hemodialysis patients. Materials and Method: 58 patients (23 men, 35 women) mat were underwent to hemodialysis three times in a week for at least six months were included. Patients that were diabetic, has a family history of diabetes, obese, unstabil and suffered from active infection were excluded. Patients were divided in two groups as L- carnitine therapy group (n:29) and placebo control group (n:29). There was not a difference between grups according to average age, duration of hemodialysis, BMI and dialysis adequacy (Kt/V). Mean age was 39±13,6 in L-carnitine grup and 39±12,8 in placebo group. L-carnitine was given 1 g IV after each dialysis for one months. 5 cc serum physiologic was given after each dialysis in placebo control group. H0MA-IR>1,93 accepted as insulin resistance. Patients were classified according to PTH levels, hematocrit values and rHuEpo treatment. HOMA-IR values were compared. Blood samples were collected at 8:30 am after 12 hours hunger. It was measured in Central Laboratory of Dicle University Medical Faculty. 64Findings: We established insulin resistance (H0MA-IR>1,93) in %24 of patients. A significant relation was'nt determined between HOMA-IR and PTH levels, hematocrit value and rHuEpo treatment (p>0,05). Significant change was'nt determined im HOMA-IR, insulin, glucose, total cholesterol, triglyceride, HDL-C, LDL-C levels after treatment in L-carnitine group (p>0,05). Also there was'nt a significant change in HOMA-IR, glucose, total cholesterol, triglyceride, HDL-C, LDL-C levels in placebo conrol group (p>0,05). Significant increase was determined in insulin levels (p<0,05). Result: We established that IR, has a predictor role on cardiovasculer mortality in ESRD, is a reversible risk factor by adequate hemodialysis therapy. L-carnitine did'nt made evident effect on IR and lipid levels. 65
Benzer Tezler
- Peyzaj düzenleme çalışmalarında kullanılan ve kullanılmaya uygun çeşitli taşların özellikleri ile İzmir ve yakın çevresinde bunlara ilişkin kaynaklar üzerinde araştırmalar
Başlık çevirisi yok
E. VECDİ KÜÇÜKERBAŞ
Yüksek Lisans
Türkçe
1985
Peyzaj MimarlığıEge ÜniversitesiPeyzaj Mimarlığı Ana Bilim Dalı
DOÇ. DR. İLÇİN ASLANBOĞA
- Dokuma kumaşlarda örgü tipinin ham kumaşın boyutları ve geometrik özellikleri üzerindeki etkilerinin araştırılması
Başlık çevirisi yok
EMEL ÖNDER
Yüksek Lisans
Türkçe
1985
Tekstil ve Tekstil MühendisliğiEge ÜniversitesiTekstil Mühendisliği Ana Bilim Dalı
DOÇ. DR. GÜNGÖR BAŞER
- Manisa yöresinde domateste anlaşmalı tarım ve karşılaşılan sorunlar
Başlık çevirisi yok
OSMAN MURAT KOÇTÜRK
Yüksek Lisans
Türkçe
1985
Gıda MühendisliğiEge ÜniversitesiTarım Ekonomisi Ana Bilim Dalı
PROF. DR. METİN TALİM
- Üzüm sularının pastörizasyonu ve kontsantresi sırasında hidroksimetilfurfural oluşumu üzerinde bir araştırma
Başlık çevirisi yok
ŞERİFE ŞAHİN
Yüksek Lisans
Türkçe
1985
Gıda MühendisliğiEge ÜniversitesiTarım Ürünleri Teknolojisi Ana Bilim Dalı
DOÇ. DR. AYDIN URAL
- New algorithms and techniques for microprocessor-controlled PWM induction drives
Başlık çevirisi yok
OSMAN KÜKRER
Doktora
İngilizce
1987
Elektrik ve Elektronik MühendisliğiOrta Doğu Teknik ÜniversitesiElektrik-Elektronik Mühendisliği Ana Bilim Dalı
PROF. DR. H. BÜLENT ERTAN